Recombinant Human KGF/FGF7
Fibroblast growth factor-7(FGF-7) is one of 22 known members of the mouse FGF family of secreted proteins that plays a key role in development, morphogenesis, angiogenesis, wound healing, and tumorigenesis [1-4]. KGF expression is restricted to cells of mesenchymal origin. When secreted, it acts as a paracrine growth factor for nearby epithelial cells [1]. KGF speeds wound healing by being dramatically upregulated in response to damage to skin or internal structures that results in high local concentrations of inflammatory mediators such as IL-1 and TNF-alpha [2, 5]. KGF promotes cell mig -ration and invasion, and mediates melanocyte transfer to keratinocytes upon UVB radiation [6, 7]. It has been used ectopically to avoid chemotherapy -induced oral mucositis in patients with hematological malignancies [1]. Deletion of KGF affects kidney development, producing abnormally small ureteric buds and fewer nephrons [8]. It also impedes hair follicle differentiation [9]. The 194 amino acid (aa) KGF precursor contains a 31 aa signal sequence and, like all other FGFs, an ~120 aa beta -trefoil scaffold that includes receptor- and heparin-binding sites. KGF signals only through the IIIb splice form of the tyrosine kinase receptor, FGF R2 (FGF R2-IIIb/KGF R) [10]. Receptor dimerization requires an octameric or larger heparin or heparin sulfate proteoglycan [11]. FGF-10, also called KGF2, shares 51% aa identity and similar function to KGF, but shows more limited expression than KGF and uses an additional receptor, FGF R2-IIIc [12]. Following receptor engagement, KGF is typically degraded, while FGF-10 is recycled [12]. Mature human KGF, which is active across species, shares 98% aa sequence identity with bovine, equine, ovine and canine, 96% with mouse and porcine, and 92% with rat KGF, respectively.
Reference
[1]. Finch, P.W. and J.S. Rubin (2006) J. Natl. Cancer Inst. 98:812.
[2]. Werner, S. et al. (2007) J. Invest. Dermatol. 127:998.
[3]. Werner, S. (1998) Cytokine Growth Factor Rev. 9:153.
[4]. Mason, I.J. et al. (1994) Mech. Dev. 45:15.
[5]. Geer, D.J. et al. (2005) Am. J. Pathol. 167:1575.
[6]. Niu, J. et al. (2007) J. Biol. Chem. 282:6001.
[7]. Cardinali, G. et al. (2005) J. Invest. Dermatol. 125:1190.
[8]. Qiao, J. et al. (1999) Development 126:547.
[9]. Guo, L. et al. (1996) Genes Dev. 10:165.
[10]. de Georgi, V. et al. (2007) Dermatol. Clin. 25:477.
[11]. Hsu, Y-R. et al. (1999) Biochemistry 38:2523.
[12]. Belleudi, F. et al. (2007) Traffic 8:1854.
Accession # |
P21781 |
Alternate Names |
FGF7; FGF-7; fibroblast growth factor 7HBGF-7; HBGF7; HBGF-7; Heparin-binding growth factor 7; |
Source |
Human embryonic kidney cell, HEK293-derived human FGF-7 protein |
Protein sequence |
Cys32-Thr194 |
M.Wt |
18.9 kDa |
Appearance |
Solution protein. |
Stability & Storage |
Avoid repeated freeze-thaw cycles. It is recommended that the protein be aliquoted for optimal storage. 12 months from date of receipt, -20 to -70 °C as supplied. |
Concentration |
0. 2 mg/mL |
Formulation |
Dissolved in sterile PBS buffer. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers. |
Biological Activity |
Measured in a cell proliferation assay using 4MBr-5 rhesus monkey epithelial cells. The EC50 for this effect is 2-20 ng/mL. |
Shipping Condition |
Shipping with dry ice. |
Handling |
Centrifuge the vial prior to opening. |
Usage |
For Research Use Only! Not to be used in humans. |
Quality Control & DataSheet
- View current batch:
-
Purity > 95%, determined by SDS-PAGE.
- Datasheet
Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.